0.2502
price up icon2.10%   0.00515
after-market After Hours: .25 -0.0002 -0.08%
loading
China Pharma Holdings Inc. stock is traded at $0.2502, with a volume of 177.84K. It is up +2.10% in the last 24 hours and up +19.20% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.245
Open:
$0.2452
24h Volume:
177.84K
Relative Volume:
0.16
Market Cap:
$4.72M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-0.7446
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-5.16%
1M Performance:
+19.20%
6M Performance:
-2.65%
1Y Performance:
-32.99%
1-Day Range:
Value
$0.2403
$0.2604
1-Week Range:
Value
$0.2368
$0.31
52-Week Range:
Value
$0.13
$0.41

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name
Name
China Pharma Holdings Inc.
Name
Phone
86 898 6681 1730
Name
Address
No. 17, Jinpan Road, Second Floor, Haikou
Name
Employee
276
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CPHI's Discussions on Twitter

Compare CPHI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CPHI
China Pharma Holdings Inc.
0.2502 4.72M 5.54M -4.74M -750.60K -0.336
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.50 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.98 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.16 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.29 17.52B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.26 13.78B 2.76B 1.11B 898.10M 22.77

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-10 Initiated Rodman & Renshaw Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

pulisher
Mar 31, 2025

China NT Pharma Reports Significant Losses for 2024 - TipRanks

Mar 31, 2025
pulisher
Mar 27, 2025

Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Big pharma faces headwinds in China as vaccine sales decline - Yahoo

Mar 26, 2025
pulisher
Mar 25, 2025

Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025 - Yahoo Finance

Mar 25, 2025
pulisher
Mar 22, 2025

China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update - Quantisnow

Mar 21, 2025
pulisher
Mar 21, 2025

Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace

Mar 21, 2025
pulisher
Mar 20, 2025

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd. - Yahoo Finance

Mar 20, 2025
pulisher
Mar 18, 2025

Hedge funds, pharma CEOs on list of attendees for China business summit - Yahoo Finance

Mar 18, 2025
pulisher
Mar 15, 2025

Prefilled Syringes Market Hits New High | Major Giants Weigao Group, YPSOMED AG , Boditech Med Inc - Newstrail

Mar 15, 2025
pulisher
Mar 13, 2025

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Is Zoetis Inc. (ZTS) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

SEC Form 10-K filed by Corbus Pharmaceuticals Holdings Inc. - Quantisnow

Mar 11, 2025
pulisher
Mar 07, 2025

Is PDD Holdings Inc. (PDD) the Cheap Chinese Stock to Buy Now? - Insider Monkey

Mar 07, 2025
pulisher
Mar 04, 2025

Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ... - Yahoo Finance

Mar 04, 2025
pulisher
Feb 27, 2025

Alliance Pharma And 2 Other UK Penny Stocks With Promising Fundamentals - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online

Feb 26, 2025
pulisher
Feb 26, 2025

Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ... - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

Can Euro Tech's $2.2M Water Treatment Deals Signal Growth in China's Environmental Tech Market? - StockTitan

Feb 25, 2025
pulisher
Feb 23, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Chinese researchers find bat virus enters human cells via same pathway as COVID - Reuters

Feb 21, 2025
pulisher
Feb 20, 2025

Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - The Manila Times

Feb 20, 2025
pulisher
Feb 19, 2025

Allspring Global Investments Holdings LLC Decreases Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - The AM Reporter

Feb 19, 2025
pulisher
Feb 18, 2025

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo

Feb 18, 2025
pulisher
Feb 18, 2025

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance

Feb 17, 2025
pulisher
Feb 17, 2025

Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance

Feb 17, 2025
pulisher
Feb 16, 2025

U.S. investors, Big Pharma race to find new medicines in China - MSN

Feb 16, 2025
pulisher
Feb 14, 2025

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

Feb 14, 2025
pulisher
Feb 14, 2025

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow

Feb 14, 2025
pulisher
Feb 10, 2025

Hong Kong Stock Exchange Companies List - Morningstar.com.au

Feb 10, 2025
pulisher
Feb 05, 2025

China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex

Feb 05, 2025
pulisher
Feb 05, 2025

Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance

Feb 05, 2025
pulisher
Feb 04, 2025

Wall Street Today: US stocks open flat amid China’s response to Trump tariffs; Nvidia up 3.19% - Mint

Feb 04, 2025
pulisher
Feb 03, 2025

China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St

Feb 03, 2025
pulisher
Feb 02, 2025

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World

Feb 02, 2025
pulisher
Jan 29, 2025

Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance

Jan 29, 2025
pulisher
Jan 29, 2025

3 Leading Dividend Stocks Including Dawnrays Pharmaceutical Holdings - Simply Wall St

Jan 29, 2025
pulisher
Jan 27, 2025

China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks

Jan 27, 2025

China Pharma Holdings Inc. Stock (CPHI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.77
price up icon 4.06%
$32.65
price up icon 0.37%
$97.42
price down icon 0.52%
$8.66
price up icon 0.70%
$108.31
price up icon 1.22%
$312.26
price up icon 1.75%
Cap:     |  Volume (24h):